VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2020 SESSION

• | print version

HB 312 Naloxone or other opioid antagonist; communication of information by Board of Pharmacy.

Introduced by: Wendy W. Gooditis | all patrons    ...    notes | add to my profiles

SUMMARY AS INTRODUCED:

Board of Pharmacy; information about naloxone. Directs the Board of Pharmacy to include in each annual license renewal communication information about the dispensing, possession, and administration of naloxone or other opioid antagonist, including information about laws governing the dispensing, possession, and administration of naloxone or other opioid antagonist and civil immunity for individuals who administer naloxone or other opioid antagonist to a person believed to be experiencing an opioid overdose.

FULL TEXT

• 12/31/19  House: Prefiled and ordered printed; offered 01/08/20 20101561D  pdf | impact statement

HISTORY

• 12/31/19  House: Prefiled and ordered printed; offered 01/08/20 20101561D
• 12/31/19  House: Referred to Committee on Health, Welfare and Institutions
• 01/28/20  House: Stricken from docket by Health, Welfare and Institutions (22-Y 0-N)